Part 4/18:
He highlights how private insurers in Switzerland and similar European countries facilitate choice and innovation while maintaining cost controls through individual insurance models. Conversely, the U.S. faces entrenched interests—hospitals, pharmaceutical companies, and regulators—that resist reforms reducing costs, due to economic and political incentives. Hospital chains, which are significant employers, often lobby against price reductions to protect jobs, demonstrating how vested interests hinder progress.